Apple To Rally Around 30%? Here Are 5 Other Price Target Changes For Thursday
Rosenblatt raised Apple Inc. (NASDAQ: AAPL) price target from $160 to $189. Rosenblatt analyst Barton Crockett also upgraded the stock from Neutral to Buy. Apple shares fell 2.3% to $146.33 in pre-market trading.
Stifel Downgrades Cognyte Software to Hold, Lowers Price Target to $6
Stifel analyst Brad Reback downgrades Cognyte Software (NASDAQ:CGNT) from Buy to Hold and lowers the price target from $8 to $6.
Cognyte Shares Fall On Disappointing Q2 Revenue Performance
Cognyte Software Ltd (NASDAQ:CGNT) reported a second-quarter FY23 non-GAAP revenue decline of 30.1% year-on-year to $81.3 million, missing the consensus of…
Cognyte Software Q2 EPS $(0.04) Beats $(0.17) Estimate, Sales $81.30M Miss $92.49M Estimate
Cognyte Software (NASDAQ:CGNT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.17) by 76.47 percent. This is a 123.53 percent decrease over earnings of $0.17 per share from
What 4 Analyst Ratings Have To Say About Cognyte Software
Analysts have provided the following ratings for Cognyte Software (NASDAQ:CGNT) within the last quarter:
Evercore ISI Group Downgrades Cognyte Software to In-Line, Lowers Price Target to $5
Evercore ISI Group analyst Kirk Materne downgrades Cognyte Software (NASDAQ:CGNT) from Outperform to In-Line and lowers the price target from $12 to $5.
InflaRx Climbs More Than 40%, Here’s 58 Biggest Movers From Yesterday
Gainers
Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.